MAP2 and melanoma: In this respect, the DNA hypomethylating drug 5-aza-(2-deoxy-)cytidine (decitabine) induced the neuronal marker gene microtubule associated protein 2 (MAP2), progressively methylated during melanoma progression, in metastatic melanoma cells.